Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
Main Authors: | Kim, Jong Man, Lee, Kwang-Woong, Song, Gi-Won, Jung, Bo-Hyun, Lee, Hae Won, Yi, Nam-Joon, Kwon, ChoonHyuck David, Hwang, Shin, Suh, Kyung-Suk, Joh, Jae-Won, Lee, Suk-Koo, Lee, Sung-Gyu |
---|---|
Format: | Online |
Language: | English |
Published: |
The Korean Association for the Study of the Liver
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066384/ |
Similar Items
-
Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study
by: Kim, Jong Man, et al.
Published: (2016) -
A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
by: Kim, Jong Man, et al.
Published: (2014) -
Comparison of Ultrasonographic Findings of Biopsy-Proven Tuberculous Lymphadenitis and Kikuchi Disease
by: Ryoo, Inseon, et al.
Published: (2015) -
Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
by: Kim, Jong Man, et al.
Published: (2015) -
Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation
by: Kim, Hyeyoung, et al.
Published: (2015)